← Back to Search

Interpersonal Psychotherapy for Depression

N/A
Waitlist Available
Led By Diana Koszycki, PhD
Research Sponsored by Hopital Montfort
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to week 12 and 6-months follow-up
Awards & highlights

Study Summary

This trial will test whether interpersonal psychotherapy (IPT) can help relieve depression in patients with Parkinson's Disease.

Eligible Conditions
  • Depression
  • Parkinson's Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to week 12 and 6-months follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to week 12 and 6-months follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Hamilton Depression Rating Scale (HAM-A)
Secondary outcome measures
Beck Anxiety Inventory (BAI)
Beck Depression Inventory (BDI)
Experiences in Close Relationship Scale-Revised (ECR-R)
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Interpersonal Psychotherapy (IPT)Experimental Treatment1 Intervention
Patients assigned to IPT will receive 12 sessions of individual therapy of approximately 50 minutes duration. Therapy will be manualized and slightly adapted to meet the needs of patients with Parkinson's Disease. Therapy focuses on one of four interpersonal events that are linked with onset or maintenance of depression (role transition, role disputes, unresolved grief, and interpersonal deficits).
Group II: Supportive Psychotherapy (SP)Active Control1 Intervention
Patients assigned to SP will receive 12 sessions of individual therapy of approximately 50 minutes duration. SP strives to create a supportive therapeutic relationship by emphasizing non-specific therapeutic interactions and techniques. Therapy will be manualized,
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Interpersonal Psychotherapy
2022
Completed Phase 4
~1670

Find a Location

Who is running the clinical trial?

Hopital MontfortLead Sponsor
13 Previous Clinical Trials
12,112 Total Patients Enrolled
1 Trials studying Depression
The Ottawa HospitalOTHER
93 Previous Clinical Trials
62,855 Total Patients Enrolled
1 Trials studying Depression
20 Patients Enrolled for Depression
Diana Koszycki, PhDPrincipal InvestigatorMontfort Hospital and the University of Ottawa
3 Previous Clinical Trials
136 Total Patients Enrolled
1 Trials studying Depression

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Efficacy of Psychotherapy for Depressed Parkinson's Disease Patients
2016. "Efficacy of Psychotherapy for Depressed Parkinson's Disease Patients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02552836.
~7 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top